ANTI-CDR3 THERAPY FOR B-CELL MALIGNANCIES

$198,494FY2012Department of the ArmyDOD

The Geneva Foundation

Investigators

View source on USAspending →

ANTI-CDR3 THERAPY FOR B-CELL MALIGNANCIES · GrantIndex